Table 5 Rate ratio with 95% CI and p-value between tested and matched cohort for administered number of non-halal medications on the 1st, 3rd, 5th, 7th, and 10th postoperative day. *Patient 1a 0 iv medication, 1b and 1c early discharge; rate ratio not determinable

Intravenous

d1

3 (0.272–33.085)

0,370

d3

< 0.001

0.024

d5

1.5 (0.094–23.981)

0.774

d7

5.6 (0.386–81.181)

0.207

d10*

-

-

Subcutaneous

d1

1.154 (0.881–1.511)

0.298

d3

1.154 (0.881–1.511)

0.298

d5

1.154 (0.881–1.511)

0.298

d7

0.862 (0.533–1.393)

0.543

d10

0.8 (0.516–1.24)

0.318

Oral

d1

0.75 (0.226–2.491)

0.639

d3

0.75 (0.075–7.468)

0.806

d5

0.6 (0.065–5.51)

0.652

d7

0.622 (0.06–6.423)

0.69

d10

1.182 (0.448–3.117)

0.736